Dr. James P. Ohr, DO
- Medicare services, 2024
- 1,655
- Medicare patients, 2024
- 341
- Part D claims, 2024
- 1,482
- Publications
- 32
- Clinical trials
- 10
- Practice address
- 201 State Street, Erie, PA 16550
- Practice phone
- Call (814) 877-6000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Ohr's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. James P. Ohr is a hematologist and oncologist in Erie, Pennsylvania
Dr. Ohr practices at UPMC Hamot in Erie, Pennsylvania, part of University of Pittsburgh Medical Center.
Dr. Ohr's NPI, 1306860085, was assigned on July 27, 2006. Dr. Ohr graduated from Philadelphia College of Osteopathic Medicine in 2000. Dr. Ohr holds Pennsylvania license OS011816.
- NPI
- 1306860085NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4183647878
- NPI enumeration date
- July 27, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (814) 877-6000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 52
- Medical school graduation
- 2000
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. James P. Ohr practices at UPMC Hamot in Erie, Pennsylvania
Dr. Ohr's primary practice is UPMC Hamot, at 201 State Street, Erie, PA 16550 in Erie County. The practice phone is (814) 877-6000.
- UPMC Hamot201 State Street, Erie, PA 16550 · Erie CountyPhone(814) 877-6000
Source: Dmand AI Affiliation Data
Dr. James P. Ohr is affiliated with 5 sites of care and 3 medical groups
Dr. Ohr's primary practice is UPMC Hamot in Erie, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Ohr is also affiliated with UPMC Magee-Womens Hospital. The medical group on file is UPMC Hillman Cancer Center. Dmand AI also links Dr. Ohr to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. James P. Ohr's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ohr practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| UPMC Hamot | Available with a free account |
| +4 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Pittsburgh Medical Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. James P. Ohr is one of 645 hematologists and oncologists in Pennsylvania
Hematology and oncology is Dr. Ohr's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ohr is licensed in Pennsylvania.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
Hematologists and oncologists near Dr. Ohr
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. James P. Ohr billed Medicare for 1,655 services in 2024
CMS data shows 1,655 Medicare services from Dr. Ohr across 9 procedure codes in 2024, for 341 Medicare patients. Medicare paid $130,801 for them.
Dr. Ohr's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,3952024: 1,3334%
- Other services
- 2023: 02024: 322
Where Dr. Ohr's Medicare services took place, 2024
- In an office1,19972%
- In a facility45628%
Dr. Ohr compared with the Pennsylvania median for hematologists and oncologists, 2024
- Dr. Ohr
- Pennsylvania median
- Medicare services
- 1,655vs 6542.5 times
- Medicare patients
- 341vs 22750% above
- Part D claims
- 1,305vs 3933.3 times
Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Ohr's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Ohr?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Ohr and other hematologists and oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. James P. Ohr treated 341 Medicare patients in 2024, average age 73
CMS counts 341 Medicare patients who saw Dr. Ohr in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Ohr's median patient age at 70, with 45% women.
Dr. Ohr's Medicare patients by age, 2024
Dr. Ohr's Medicare patients by sex, 2024
- Women15345%
- Men18855%
Chronic conditions among Dr. Ohr's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer44%
- Arthritis43%
- Diabetes38%
- Ischemic heart disease33%
- Anxiety32%
- Mood disorders32%
Share of Medicare patients with each condition. A patient can have several.
Dr. Ohr's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women45%
- Men55%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. James P. Ohr wrote 1,482 Medicare Part D claims in 2024
In 2024, Dr. Ohr wrote 1,482 Medicare Part D claims for 214 patients. 86% of them were for generic drugs. CMS names the drug for 1,305 of them, across 33 drugs with 11 or more claims each, at $1,786,790 in total drug cost. In 2023, CMS named 1,055 claims across 31 drugs.
Dr. Ohr's Part D claims by kind of drug, 2024
- Generic1,280 claims86%
- Brand-name202 claims14%
Dr. Ohr's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Ohr's Part D claims, 2024
- Opioids10%149 of 1,482 claims
- Antibiotics5%67 of 1,482 claims
- Antipsychotics, patients 65 and over1%16 of 1,482 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,0552024: 1,30524%
Drugs named by CMS: 33 in 2024, 31 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. James P. Ohr takes part in Medicare
Dr. Ohr accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. James P. Ohr has 32 publications on record
Dmand AI links 32 papers to Dr. Ohr, published from 2011 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck and Antineoplastic Agents, Immunological. Dr. Ohr has published most often in Clin Cancer Res. Dr. Ohr's most frequent co-authors are Dwight Earl Heron, MD, Robert Louis Ferris, MD and Seungwon Kim.
Dr. Ohr's papers by year, 2014 to 2025
Topics Dr. Ohr writes about most
- Head and Neck Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Antineoplastic Agents, Immunological
- Antineoplastic Combined Chemotherapy Protocols
- Cetuximab
- Radiosurgery
- Antibodies, Monoclonal, Humanized
- Carcinoma, Squamous Cell
Dr. Ohr's most frequent co-authors
- Dwight Earl Heron, MD16 shared papers
- Robert Louis Ferris, MD12 shared papers
- Seungwon Kim12 shared papers
Recent publications by Dr. Ohr
Int J Radiat Oncol Biol Phys
Laryngoscope Investig Otolaryngol
See who Dr. Ohr researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Ohr works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. James P. Ohr has worked on 10 clinical trials
Dmand AI links Dr. Ohr to 10 clinical trials, 4 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Snyder Robinson syndrome, Carcinoma, Medullary and Carcinoma, Non-Small-Cell Lung. Heath Skinner sponsors the most, 2.
Clinical trials with Dr. Ohr by phase
- NonePhase 1: no trials
- 4Phase 2: 4 trials
- 2Phase 2/3: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. Ohr's trials
- Snyder Robinson syndrome
- Carcinoma, Medullary
- Carcinoma, Non-Small-Cell Lung
- Fallopian Tube Diseases
- Head and Neck Neoplasms
Investigators on the most trials with Dr. Ohr
- Dwight Earl Heron, MD4 shared trials
- Steven A. Burton, MD3 shared trials
- Brian J. Karlovits, DO3 shared trials
Recent clinical trials with Dr. Ohr
FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer (opens in a new tab)
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer (opens in a new tab)
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. James P. Ohr received $18,562 in industry payments from 2016 to 2025
CMS Open Payments shows 32 general payments to Dr. Ohr from 8 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Bristol-Myers Squibb Company paid the most, $10,531.
General payments to Dr. Ohr by program year, 2016 to 2025
General payments to Dr. Ohr by kind, 2016 to 2025
- Speaker and faculty fees$12,69568%
- Consulting fees$4,15322%
- Food and beverage$1,5498%
- Education$900%
- Travel and lodging$750%
Companies that paid Dr. Ohr the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. James P. Ohr graduated from Philadelphia College of Osteopathic Medicine
Dr. Ohr graduated from Philadelphia College of Osteopathic Medicine in 2000.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. James P. Ohr's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. James P. Ohr
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. James P. Ohr's NPI number?
Dr. James P. Ohr's NPI number is 1306860085. It was assigned on July 27, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. James P. Ohr?
Dr. James P. Ohr is a hematologist and oncologist in Erie, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. James P. Ohr practice?
Dr. Ohr practices at 201 State Street, Erie, PA 16550. Dr. Ohr's primary practice is UPMC Hamot in Erie, Pennsylvania, part of University of Pittsburgh Medical Center. Dmand AI also links Dr. Ohr to 1 hospital, 2 group practices and clinics and 2 medical groups.
What is Dr. James P. Ohr's office phone number?
The practice phone on file for Dr. Ohr is (814) 877-6000.
What is Dr. James P. Ohr's medical license number?
Dr. Ohr holds Pennsylvania license OS011816.
Which hospitals is Dr. James P. Ohr affiliated with?
Dr. Ohr practices at UPMC Hamot in Erie, Pennsylvania. Dr. Ohr is also affiliated with UPMC Magee-Womens Hospital. Dmand AI links Dr. Ohr to 1 more hospital.
What medical group is Dr. James P. Ohr part of?
Dr. Ohr is linked to UPMC Hillman Cancer Center. Dmand AI links Dr. Ohr to 2 more medical groups.
Does Dr. James P. Ohr accept Medicare?
Yes. CMS data shows Dr. Ohr billed Medicare for 1,655 services in 2024, and Dr. Ohr accepts Medicare assignment.
How many Medicare patients does Dr. James P. Ohr see?
CMS counts 341 Medicare patients who saw Dr. Ohr in 2024, with an average age of 73.
What services does Dr. James P. Ohr bill to Medicare?
In 2024, Dr. Ohr's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and hospital inpatient care (99233).
Show 6 more questionsShow fewer questions
Where did Dr. James P. Ohr go to medical school?
Dr. Ohr graduated from Philadelphia College of Osteopathic Medicine in 2000.
What drugs does Dr. James P. Ohr prescribe most?
In 2024 Medicare Part D data, Dr. Ohr's most prescribed drugs by claims were Levothyroxine Sodium, Prednisone and Abiraterone Acetate.
Has Dr. James P. Ohr received payments from drug or device companies?
CMS Open Payments shows $18,562 in general payments to Dr. Ohr from 8 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. James P. Ohr been practicing?
Dr. Ohr graduated from medical school in 2000, 26 years ago.
Does Dr. James P. Ohr do research?
Dmand AI links 32 publications to Dr. Ohr, published from 2011 to 2025. Dr. Ohr has worked on 10 clinical trials.
Who does Dr. James P. Ohr publish with?
Dr. Ohr's most frequent co-authors are Dwight Earl Heron, MD (16 shared papers), Robert Louis Ferris, MD (12 shared papers) and Seungwon Kim (12 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card